CAM

Cormorant Asset Management Portfolio holdings

AUM $1.76B
1-Year Est. Return 415.22%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+415.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.76B
AUM Growth
+$315M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
42
New
Increased
Reduced
Closed

Top Buys

1
+$48.9M
2
+$27.9M
3
+$20.7M
4
ENGN icon
enGene Therapeutics Inc. Common Stock
ENGN
+$13.4M
5
ALMS
Alumis Inc
ALMS
+$10.4M

Top Sells

1
+$65.5M
2
+$63.6M
3
+$42.8M
4
INSM icon
Insmed
INSM
+$28.3M
5
CGON icon
CG Oncology
CGON
+$25.2M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXSM icon
26
Axsome Therapeutics
AXSM
$9.43B
$13.7M 0.78%
75,000
-25,000
CABA icon
27
Cabaletta Bio
CABA
$377M
$9.64M 0.55%
4,400,000
-600,000
JANX icon
28
Janux Therapeutics
JANX
$913M
$8.97M 0.51%
650,000
-200,000
COGT icon
29
Cogent Biosciences
COGT
$5.91B
$7.99M 0.45%
+225,000
PCVX icon
30
Vaxcyte
PCVX
$8.76B
$5.77M 0.33%
125,000
-50,000
AMLX icon
31
Amylyx Pharmaceuticals
AMLX
$1.87B
$4.83M 0.27%
400,000
-100,000
BHVN icon
32
Biohaven
BHVN
$1.56B
$113K 0.01%
10,000
ACLX icon
33
Arcellx
ACLX
$6.73B
– –
-775,000
BMEA icon
34
Biomea Fusion
BMEA
$140M
– –
-3,570,872
CGON icon
35
CG Oncology
CGON
$5.7B
– –
-625,000
ELVN icon
36
Enliven Therapeutics
ELVN
$2.62B
– –
-200,000
IWM icon
37
iShares Russell 2000 ETF
IWM
$75.3B
– –
0
KRRO icon
38
Korro Bio
KRRO
$196M
– –
-465,000
QQQ icon
39
Invesco QQQ Trust
QQQ
$412B
– –
0
RNAM
40
DELISTED
Avidity Biosciences
RNAM
– –
-300,000
XBI icon
41
State Street SPDR S&P Biotech ETF
XBI
$8.79B
– –
0
MTSR
42
DELISTED
Metsera Inc
MTSR
– –
-400,000
1
2